- Home
- DV vs CPRX Comparison
DV vs CPRX Comparison
Compare DV & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- CPRX
- Stock Information
- Founded
- DV 2008
- CPRX 2002
- Country
- DV United States
- CPRX United States
- Employees
- DV N/A
- CPRX N/A
- Industry
- DV Computer Software: Prepackaged Software
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- CPRX Health Care
- Exchange
- DV Nasdaq
- CPRX Nasdaq
- Market Cap
- DV 2.4B
- CPRX 2.6B
- IPO Year
- DV 2021
- CPRX 2006
- Fundamental
- Price
- DV $15.56
- CPRX $21.28
- Analyst Decision
- DV Buy
- CPRX Strong Buy
- Analyst Count
- DV 18
- CPRX 6
- Target Price
- DV $18.92
- CPRX $32.83
- AVG Volume (30 Days)
- DV 1.8M
- CPRX 1.2M
- Earning Date
- DV 08-05-2025
- CPRX 08-06-2025
- Dividend Yield
- DV N/A
- CPRX N/A
- EPS Growth
- DV N/A
- CPRX 178.13
- EPS
- DV 0.29
- CPRX 1.57
- Revenue
- DV $681,128,000.00
- CPRX $534,645,999.00
- Revenue This Year
- DV $16.02
- CPRX $16.37
- Revenue Next Year
- DV $11.68
- CPRX $8.80
- P/E Ratio
- DV $53.52
- CPRX $13.57
- Revenue Growth
- DV 15.30
- CPRX 29.97
- 52 Week Low
- DV $11.52
- CPRX $15.34
- 52 Week High
- DV $23.11
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- DV 55.74
- CPRX 45.48
- Support Level
- DV $15.41
- CPRX $20.76
- Resistance Level
- DV $16.12
- CPRX $21.30
- Average True Range (ATR)
- DV 0.43
- CPRX 0.61
- MACD
- DV -0.01
- CPRX 0.09
- Stochastic Oscillator
- DV 64.10
- CPRX 45.33
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).